Reduction of in vivo tumor growth by MMI-166, a selective matrix metalloproteinase inhibitor, through inhibition of tumor angiogenesis in squamous cell carcinoma cell lines of head and neck.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples